中东和非洲血尿治疗市场预测至 2028 年 - COVID-19 影响和治疗(药物、疗法等)、适应症(尿路感染、肾结石、尿道炎、血癌、膀胱结石、前列腺癌、膀胱炎)的区域分析、创伤、剧烈运动、多囊肾病、子宫内膜异位症和月经)、类型(肉眼血尿、显微镜下血尿、特发性血尿和慢跑者血尿)、最终用户(医院、诊所和门诊手术中心等)

TIPRE00026251 | Pages: 170 | Pharmaceuticals | Dec 2021 | Type: Regional | Status: Published

市场介绍

血尿是一种在尿液中发现血液的疾病。一般来说,尿液中不含红细胞,因此可能会导致严重的问题,还可能导致肾结石、尿路感染和其他遗传性疾病。

此外,血尿的患病率很高预计相关迹象将在预测期内促进市场增长。然而,相关适应症的未确诊病例限制了中东和非洲地区的增长。非洲血尿治疗市场。

在中东和非洲地区,重症监护病房 (ICU) 住院的患者人数不断增加,处方药物数量也在增加,导致许多诊断以及已经不堪重负的医疗保健系统的治疗问题。 COVID-19 症状主要见于肺部系统,但泌尿生殖系统的表现和/或后果要特别注意。老年 CKD 患者发生严重感染的风险较高,而 AKI 与高死亡率相关。因此,有必要监测重症COVID-19患者的肾功能,CRRT保护肾功能和消除危重患者的细胞因子对于改善康复至关重要。另一方面,COVID-19 感染似乎会对泌尿生殖道产生影响。治疗 COVID-19 时,应考虑泌尿生殖器官。

市场概况和动态

中东和中东地区非洲血尿治疗市场预计将从2021年的4200万美元增至2028年的4680万美元;预计 2021 年至 2028 年复合年增长率为 1.5%。慢性肾病 (CKD) 是一种常见且危及生命的疾病,影响更多人群。 CKD 有多种类型,如肾结石、肾小球肾炎、多囊肾和尿路感染。 CKD 是血尿流行的主要原因之一。此外,65岁以上女性的尿路感染患病率约为20%,而总人口的患病率约为11%。目前,中东和非洲非洲血尿治疗市场因相关适应症的日益流行而显着增长。

主要细分市场

从类型上看,肉眼血尿段在中东和中东地区所占比例最大。 2020年非洲血尿治疗市场。在治疗方面,药物细分市场占中东及非洲地区最大份额。 2020年非洲血尿治疗市场。从适应症来看,中东和非洲尿路感染细分市场占据最大份额。 2020年非洲血尿治疗市场。就最终用户而言,医院细分市场占据中东和非洲地区最大份额。 2020年非洲血尿治疗市场。

主要来源和上市公司

准备这份关于中东和中东地区血尿治疗市场的报告时提到了一些主要的一手和二手资料来源。非洲有公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括阿斯利康、百时美施贵宝公司、F. HOFFMANN-LA ROCHE LTD.、葛兰素史克公司、杨森制药、默沙东制药公司和默沙东制药公司。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd 和 Boehringer Ingelheim International GmbH。

购买原因报告

  • 了解中东和中东地区非洲血尿治疗市场格局并确定可能保证丰厚回报的细分市场
  • 了解不断变化的市场格局并在竞争中保持领先
  • 有效规划中东和非洲地区的并购和合作交易。通过识别最有希望销售的细分市场,非洲血尿治疗市场
  • 通过对各个细分市场的市场表现进行敏锐和全面的分析,做出明智的业务决策
  • 获取中东及中东地区市场收入预测2021年至2028年按不同细分市场划分的非洲血尿治疗市场

中东和非洲非洲血尿治疗市场细分

作者治疗

  • 药物
  • 疗法
  • 其他

按指示

  • 尿路感染
  • 肾结石
  • 尿道炎
  • 血癌
  • 膀胱结石
  • 前列腺癌
  • 膀胱炎
  • 外伤
  • 剧烈运动
  • 多囊肾
  • 子宫内膜异位症
  • 月经
  • 子宫内膜异位症
  • 月经
  • span>

类型

  • 肉眼血尿
  • 显微镜下血尿
  • 特发性血尿
  • 慢跑者血尿

最终用户

  • 医院
  • 诊所
  • 门诊手术中心 (ASC)
  • 其他

按国家/地区

  • 中东和中东非洲
    • 阿联酋
    • 沙特阿拉伯
    • 南非
    • 中东其他地区和地区非洲

提及的公司

< ul>
  • 阿斯利康
  • 百时美施贵宝公司
  • F. HOFFMANN-LA ROCHE LTD.
  • 葛兰素史克公司
  • 杨森制药
  • 默克公司有限公司
  • 诺华公司
  • 辉瑞公司
  • < span>太阳制药工业有限公司
  • 勃林格殷格翰国际有限公司
  • TABLE OF CONTENTS

    1.           Introduction

    1.1         Scope of the Study

    1.2         The Insight Partners Research Report Guidance

    1.3         Market Segmentation

    1.3.1        Middle East & Africa Hematuria Treatment Market – By Treatment

    1.3.2        Middle East & Africa Hematuria Treatment Market – By Indication

    1.3.3        Middle East & Africa Hematuria Treatment Market – By Type

    1.3.4        Middle East & Africa Hematuria Treatment Market – By End User

    1.3.5        Middle East & Africa Hematuria Treatment Market – By Country

    2.           Middle East & Africa Hematuria Treatment Market – Key Takeaways

    3.        Research Methodology

    3.1         Coverage

    3.2         Secondary Research

    3.3         Primary Research

    4.           Hematuria Treatment Market – Market Landscape

    4.1         Overview

    4.2         PEST Analysis

    4.2.1        Middle East & Africa – PEST Analysis

    4.3         Experts Opinion

    5.           Hematuria Treatment Market – Key Market Dynamics

    5.1         Market Drivers

    5.1.1        High Prevalence of Hematuria-Associated Indications

    5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

    5.2         Market Restraints

    5.2.1        Undiagnosed Cases of Associated Indications

    5.3         Market Opportunities

    5.3.1        Increasing Opportunities for Related Treatments

    5.4         Future Trends

    5.4.1        Rise in Preference for Advanced Therapies

    5.5         Impact Analysis

    6.           Hematuria Treatment Market – Middle East & Africa Analysis

    6.1         Middle East & Africa Hematuria Treatment Market Revenue Forecast and Analysis

    7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

    7.1         Overview

    7.2         Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

    7.3         Drugs

    7.3.1        Overview

    7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    7.4         Therapies

    7.4.1        Overview

    7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    7.5         Others

    7.5.1        Overview

    7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

    8.1         Overview

    8.2         Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

    8.3         Kidney Stones

    8.3.1        Overview

    8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.4         Urinary Tract Infections (UTI)

    8.4.1        Overview

    8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.5         Urethritis

    8.5.1        Overview

    8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.6         Blood Cancer

    8.6.1        Overview

    8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.7         Bladder Stones

    8.7.1        Overview

    8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.8         Prostate Cancer

    8.8.1        Overview

    8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.9         Cystitis

    8.9.1        Overview

    8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.10      Trauma

    8.10.1     Overview

    8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.11      Vigorous Exercise

    8.11.1     Overview

    8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.12      Polycystic Kidney Disease

    8.12.1     Overview

    8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.13      Endometriosis

    8.13.1     Overview

    8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    8.14      Menstruation

    8.14.1     Overview

    8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

    9.1         Overview

    9.2         Middle East & Africa Hematuria Treatment Market, By Type 2020 & 2028 (%)

    9.3         Macroscopic Hematuria

    9.3.1        Overview

    9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    9.4         Microscopic Hematuria

    9.4.1        Overview

    9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    9.5         Idiopathic Hematuria

    9.5.1        Overview

    9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    9.6         Jogger’s Hematuria

    9.6.1        Overview

    9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

    10.1      Overview

    10.2      Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)

    10.3      Hospitals

    10.3.1     Overview

    10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    10.4      Clinics

    10.4.1     Overview

    10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    10.5      Ambulatory Surgical Centers (ASC’s)

    10.5.1     Overview

    10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    10.6      Others

    10.6.1     Overview

    10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

    11.        Middle East & Africa Hematuria Treatment Market – Geographic Analysis

    11.1      Middle East & Africa: Hematuria Treatment Market

    11.1.1     Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    11.1.2     Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

    11.1.3     Middle East & Africa: Hematuria Treatment Market, by Indication - Revenue and Forecast to 2028 (USD Million)

    11.1.4     Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

    11.1.5     Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

    11.1.6     Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)

    11.1.6.1       Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    11.1.6.1.1       Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    11.1.6.1.2       Saudi Arabia: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

    11.1.6.1.3       Saudi Arabia: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

    11.1.6.1.4       Saudi Arabia: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

    11.1.6.1.5       Saudi Arabia: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

    11.1.6.2       South Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)

    11.1.6.2.1       South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    11.1.6.2.2       South Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

    11.1.6.2.3       South Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

    11.1.6.2.4       South Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

    11.1.6.2.5       South Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

    11.1.6.3       UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    11.1.6.3.1       UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    11.1.6.3.2       UAE: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

    11.1.6.3.3       UAE: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

    11.1.6.3.4       UAE: Hematuria Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)

    11.1.6.3.5       UAE: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

    11.1.6.4       Rest of Middle East & Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)

    11.1.6.4.1       Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    11.1.6.4.2       Rest of Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

    11.1.6.4.3       Rest of Middle East & Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

    11.1.6.4.4       Rest of Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

    11.1.6.4.5       Rest of Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

    12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market

    12.1      Middle East & Africa: Impact Assessment of COVID-19 Pandemic

    13.        Hematuria Treatment Market–Industry Landscape

    13.1      Overview

    13.2      Growth Strategies Done by the Companies in the Market, (%)

    13.3      Organic Developments

    13.3.1     Overview

    13.4      Inorganic Developments

    13.4.1     Overview

    14.        Company Profiles

    14.1      AstraZeneca

    14.1.1     Key Facts

    14.1.2     Business Description

    14.1.3     Products and Services

    14.1.4     Financial Overview

    14.1.5     SWOT Analysis

    14.1.6     Key Developments

    14.2      Bristol-Myers Squibb Company

    14.2.1     Key Facts

    14.2.2     Business Description

    14.2.3     Products and Services

    14.2.4     Financial Overview

    14.2.5     SWOT Analysis

    14.2.6     Key Developments

    14.3      F. HOFFMANN-LA ROCHE LTD.

    14.3.1     Key Facts

    14.3.2     Business Description

    14.3.3     Products and Services

    14.3.4     Financial Overview

    14.3.5     SWOT Analysis

    14.3.6     Key Developments

    14.4      GlaxoSmithKline Plc

    14.4.1     Key Facts

    14.4.2     Business Description

    14.4.3     Products and Services

    14.4.4     Financial Overview

    14.4.5     SWOT Analysis

    14.4.6     Key Developments

    14.5      Janssen Pharmaceuticals

    14.5.1     Key Facts

    14.5.2     Business Description

    14.5.3     Products and Services

    14.5.4     Financial Overview

    14.5.5     SWOT Analysis

    14.5.6     Key Developments

    14.6      Merck & Co., Inc.

    14.6.1     Key Facts

    14.6.2     Business Description

    14.6.3     Products and Services

    14.6.4     Financial Overview

    14.6.5     SWOT Analysis

    14.6.6     Key Developments

    14.7      Novartis AG

    14.7.1     Key Facts

    14.7.2     Business Description

    14.7.3     Products and Services

    14.7.4     Financial Overview

    14.7.5     SWOT Analysis

    14.7.6     Key Developments

    14.8      Pfizer Inc.

    14.8.1     Key Facts

    14.8.2     Business Description

    14.8.3     Products and Services

    14.8.4     Financial Overview

    14.8.5     SWOT Analysis

    14.8.6     Key Developments

    14.9      Sun Pharmaceutical Industries Ltd

    14.9.1     Key Facts

    14.9.2     Business Description

    14.9.3     Products and Services

    14.9.4     Financial Overview

    14.9.5     SWOT Analysis

    14.9.6     Key Developments

    14.10   Boehringer Ingelheim International GmbH

    14.10.1  Key Facts

    14.10.2  Business Description

    14.10.3  Products and Services

    14.10.4  Financial Overview

    14.10.5  SWOT Analysis

    14.10.6  Key Developments

    15.        Appendix

    15.1      About The Insight Partners

    15.2      Glossary of Terms

     


    LIST OF TABLES

    Table 1.             Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

    Table 2.             Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

    Table 3.             Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

    Table 4.             Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 5.             Saudi Arabia Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

    Table 6.             Saudi Arabia Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

    Table 7.             Saudi Arabia Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

    Table 8.             Saudi Arabia Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 9.             South Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

    Table 10.          South Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

    Table 11.          South Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

    Table 12.          South Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 13.          UAE Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

    Table 14.          UAE Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

    Table 15.          UAE Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

    Table 16.          UAE Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 17.          Rest of Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

    Table 18.          Rest of Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

    Table 19.          Rest of Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

    Table 20.          Rest of Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 21.          Organic Developments Done by Companies

    Table 22.          Inorganic Developments Done by Companies

    Table 23.          Glossary of Terms, Hematuria Treatment Market

     


    LIST OF FIGURES

    Figure 1.           Hematuria Treatment Market Segmentation

    Figure 2.           Middle East & Africa Hematuria Treatment Market Overview

    Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

    Figure 4.           UAE to Show Significant Growth During Forecast Period

    Figure 5.           Middle East & Africa Hematuria Treatment Market, Industry Landscape

    Figure 6.           Middle East & Africa PEST Analysis

    Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints

    Figure 8.           Middle East & Africa Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

    Figure 9.           Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

    Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 13.        Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

    Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 26.        Middle East & Africa Hematuria Treatment Market, by Type 2020 & 2028 (%)

    Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

    Figure 31.        Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)

    Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

    Figure 36.        Middle East & Africa: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)

    Figure 37.        Middle East & Africa Hematuria Treatment Market Revenue and Forecast to 2028 (USD Million)

    Figure 38.        Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)

    Figure 39.        Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    Figure 40.        South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    Figure 41.        UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    Figure 42.        Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

    Figure 43.        Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets

    Figure 44.        Growth Strategies Done by the Companies in the Market, (%)

    1. AstraZeneca
    2. Bristol-Myers Squibb Company
    3. F. HOFFMANN-LA ROCHE LTD.
    4. GlaxoSmithKline plc.
    5. Janssen Pharmaceuticals
    6. Merck & Co., Inc.
    7. Novartis AG
    8. Pfizer Inc.
    9. Sun Pharmaceutical Industries Ltd
    10. Boehringer Ingelheim International GmbH
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa hematuria treatment market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3000
    $1800
    Site License
    $4000
    $2400
    Enterprise License
    $5000
    $3000